CANDICE HAYES: Open Payments
NPI 1053920181 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 50 payments from 24 companies in 2025. Trend: 2023 $240 · 2024 $1,276 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $200 |
| ABBVIE INC. | 6 | $108 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Bausch Health US, LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: Ozempic, HETLIOZ, REXULTI, Auvelity, VRAYLAR, QULIPTA, MOUNJARO, The Cologuard Plus Collection Kit.
Industry payments across NC — which companies pay providers there.
